Michael R Hoane Selected Research

Brain Contusion

1/2019	Effects of nicotinamide on spatial memory and inflammation after juvenile traumatic brain injury.
9/2015	Effect of Traumatic Brain Injury, Erythropoietin, and Anakinra on Hepatic Metabolizing Enzymes and Transporters in an Experimental Rat Model.
6/2015	A Combination Therapy of Nicotinamide and Progesterone Improves Functional Recovery following Traumatic Brain Injury.
5/2014	Comparison of the effect of minocycline and simvastatin on functional recovery and gene expression in a rat traumatic brain injury model.
1/2013	The impact of enriched environment and transplantation of murine cortical embryonic stem cells on recovery from controlled cortical contusion injury.
1/2013	Comparison of the effects of erythropoietin and anakinra on functional recovery and gene expression in a traumatic brain injury model.
12/2012	A comparison of the effects of nicotinamide and progesterone on functional recovery of cognitive behavior following cortical contusion injury in the rat.
10/2012	A discrimination task used as a novel method of testing decision-making behavior following traumatic brain injury.
9/2011	The effects of a high-fat sucrose diet on functional outcome following cortical contusion injury in the rat.
9/2011	The effect of progesterone dose on gene expression after traumatic brain injury.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael R Hoane Research Topics

Disease

20	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2019 - 04/2003
18	Brain Contusion 01/2019 - 05/2006
10	Wounds and Injuries (Trauma) 01/2019 - 11/2003
8	Brain Injuries (Brain Injury) 01/2016 - 06/2002
7	Contusions 07/2010 - 11/2003
3	Inflammation (Inflammations) 01/2019 - 12/2012
3	Edema (Dropsy) 12/2012 - 10/2005
2	Cognitive Dysfunction 12/2010 - 04/2003
2	Ischemia 11/2006 - 11/2003
2	Infarction (Infarctions) 11/2006 - 11/2003
1	Infections 09/2015
1	Obesity 09/2011
1	Hypertension (High Blood Pressure) 09/2011
1	Retrograde Amnesia 12/2010
1	Craniocerebral Trauma (Head Injury) 07/2007
1	Necrosis 12/2006
1	Brain Edema (Cerebral Edema) 11/2006
1	Apnea 10/2006
1	Stroke (Strokes) 10/2005
1	Neurodegenerative Diseases (Neurodegenerative Disease) 08/2004

Drug/Important Bio-Agent (IBA)

10	salicylhydroxamic acid (SHAM)IBA 01/2019 - 11/2003
10	Niacinamide (Nicotinamide)FDA LinkGeneric 01/2019 - 11/2003
7	MagnesiumIBA 01/2018 - 06/2002
3	Progesterone FDA LinkGeneric 06/2015 - 09/2011
3	Apolipoproteins E (ApoE)IBA 12/2010 - 07/2007
3	ApolipoproteinsIBA 12/2010 - 07/2007
3	Peptides (Polypeptides)IBA 12/2010 - 07/2007
3	COG1410IBA 12/2010 - 07/2007
3	Magnesium Chloride FDA LinkGeneric 12/2007 - 01/2005
2	Pharmaceutical PreparationsIBA 01/2016 - 09/2015
2	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 09/2015 - 01/2013
2	Erythropoietin FDA Link 09/2015 - 01/2013
2	Low Density Lipoprotein Receptor-Related Protein-1 (LDL-Receptor Related Protein)IBA 01/2009 - 07/2007
2	Riboflavin (Vitamin B2)FDA LinkGeneric 05/2006 - 10/2005
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2016
1	Carnitine (L-Carnitine)FDA LinkGeneric 01/2016
1	VitaminsIBA 01/2016
1	ZincIBA 01/2016
1	FlavonoidsIBA 01/2016
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 09/2015
1	EnzymesIBA 09/2015
1	Proteins (Proteins, Gene)FDA Link 09/2015
1	Glucuronosyltransferase (UDP Glucuronosyltransferase)IBA 09/2015
1	Simvastatin (Zocor)FDA LinkGeneric 05/2014
1	Minocycline (Cyclops)FDA LinkGeneric 05/2014
1	Sucrose (Saccharose)IBA 09/2011
1	Pyridoxine (Pyridoxin)FDA LinkGeneric 07/2010
1	Neuroprotective AgentsIBA 12/2006
1	Selective Estrogen Receptor Modulators (SERM)IBA 06/2006
1	Raloxifene Hydrochloride (Evista)FDA Link 06/2006
1	2,5-dichloro-4-bromophenol (B 2)IBA 05/2006
1	Glial Fibrillary Acidic ProteinIBA 10/2005
1	L 644711 (B-3(+))IBA 11/2003

Therapy/Procedure

9	Therapeutics 01/2016 - 06/2002
2	Injections 01/2019 - 03/2011
1	Craniotomy 06/2015
1	Transplantation 01/2013
1	Nasoalveolar Molding 10/2008
1	Drug Therapy (Chemotherapy) 01/2005